RT Journal Article
SR Electronic
T1 330 Combination therapy with stem cell derived natural killer cells and monoclonal antibodies leads to potent ADCC through engagement of endogenouse CD16
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A377
OP A377
DO 10.1136/jitc-2023-SITC2023.0330
VO 11
IS Suppl 1
A1 Georgoudaki, Anna-Maria
A1 Lamers-Kok, Nina
A1 Vliet, Amanda van
A1 Özkazanc, Didem
A1 Vodegel, Denise
A1 Steenmans, Daniëlle
A1 Raimo, Monica
A1 Duru, Adil
A1 Spanholtz, Jan
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A377.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.